[click here and type company name]

E M O R Y U N I V E R S I T Y D E P A R T M E N T O F S U R G E R Y REPAIR SYSTEM (APTUS DEVICE), AN INVESTIGATIONAL DEVICE, USED IN THE TREATMENT OF ABDOMINAL AORT THORACIC ENDOPROSTHESIS IN SUBJECTS W/DESCENDING THORACIC AORTIC ANEURSYMS INVESTIGATIONAL DEVICE FOR INTRA-BRONCHIAL TREATMENT LONG-TERM SAFETY, AND TOLERABILITY OF TACROLIMUS IN STABLE PEDIATRIC LIVER TRANSPLANT PATIENTS CONVERTED 6-37950 BRISTOL-MYERS AI463-048-049 7/1/2003 6/30/2011 REF CHRONICALLY INFECTED HBV SUBJECTS WITH EVIDENCE OF LAMIVUDINE RESISTANCE AND HEPATIC DECOMPENSATION ASSESS THE EFFICACY AND SAFETY OF PROPHYLACTIC USE OF MARIBAVIR VS. VENTRICULAR ASSIST DEVICE-PEDIATRIC CLINICAL IDE STUDY G050262 VERSION 8 REVERSE FLOW (EMPiRE) STUDY of the GORE NEURO PROTECTION SYSTEM IN CAROTID STENTING OF SUBJECTS AT HIGH RISK CAROTID EDWARDS SELF-EXPANDING LIFESTENT VS ANGIOPLASTY-ALONE IN LESIONS FOR HIGH RISK SURGICAL SUBJECTS GORE EMBOLDEN THE RESOLUTION OF ARTERIAL AND VENOUS OCCLUSIONS STUDY TERAS ENDOPROSTHESIS FOR THE TREATMENT OF COMPLEX PATHOLOGY PROTECTION IN PTS AT HIGH TISK FOR ENDARTERECTOMY (SAPPHIRE) BLEATACEPT FOR RENAL 6-39845 BRISTOL-MYERS IM103-056 3/27/2009 AND ALEMTUZUMAB IN RENAL TRANSPLANTATION IMMUNE RESPONSE TO PORCINE ISLET XENOGRAFTS THYMOGLOBULIN TO FACILITATE ALLOANTIBODY DESENSITZATION IN RHESUS MACQUES 6-37629 BRISTOL-MYERS BMS-224818 2/1/2001 8/31/2010 PHARMACOECONOMIC STUDY COMPARING ARGATROBAN IV VS. DESIRUDIN SC FOR PTS W/SUSPECTED HERPARIN-INDUCED THROMBOCYTOPENIA AUTOLOGOUS BONE MARROW CELLS IN PTS W/HEART FAILURE DUE TO DILATED CARDIOMYOPATHY PTS W/STAGE 1A NON-SMALL CELL LUNG CANCER STUDY OF SUBLOBAR RESECTION VERSUS SUBLOBAR RESECTION PLUS BRACHYTHERAPY IN HIGH RISK PATIENTS WITH NON-CELL LUNG CANCER VS SUBLOBAR RESECTION FOR SMALL PERIPHERAL NON-SMALL CELL LUNG CANCER OF SERUM SAMPLES FOR DETECTION OF NON-SMALL CELL LUNG CANCER PATIENTS WHO ARE POTENTIAL CANDIDATES FOR SURGICAL RESECTION CONTROLLED, SUPERIORITY EVALUATION OF FIBRIN PATCH AS AN ADJUCT TO CONTROL SOFT TISSUE BLEEDING ENDOSURE SENSOR FOR LONG TERM FOLLOW-UP AFTER EVAR ENDOLUMINAL STENT GRAFT FOR REPAIR OF AAA IN PATIENTS ENDOPROSTHESIS FOR THE PRIMARY RX OF ANEURYSMS CARDIOMEMS ABDOMINAL AORTIC ANEURSYM PRESSURE SENSOR SYSTEM WITH EV3 ARTIERIAL TECHNOLOGY EVOLUTION POST APPROVAL STUDY (CREATE-PAS) OF EARLY CONVERSION FROM TACROLIMUS TO EFLAIZUMAB MAINTENANCE THERAPY LABEL, ACTIVE CONTROLLED, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND EFFICIACY OF EFALIZUMAB 6-38050 BRISTOL-MYERS IM103-008 2/13/2006 NEPHROPROTECTION AND EFFICIACY AS FIRST-LINE IMMUNO-SUPPRESSION TRIAL-BENEFIT 6-37198 BRISTOL-MYERS IM103027 1/28/2005 NEPHROPROTECTION & EFFICACY AS FIRST-LINE IMMUNO REPAIR/REPLACEMENTS IN SEVERE CHRONIC ISCHEMIC MITRAL VALVE REGURGITATION PATIENTS WITH DIABETES MELLITUS: OPTIMAL STUDY TO EVALUATE EMBOLIC PARTICULATE DRUING OPCAB RESTRAINT TO LESSEN THE EFFECTS OF HEART FAILURE SURGICAL TREATMENT FOR OFF-PUMP REPAIR OF THE MITRAL VALVE (RESTOR-MV) AND EFFICACY OF THE RELAY THORACIC STENT-GAFT IN PATIENTS WITH THORACIC AORTIC Ad5IGF-1 AND Ad5FGF-2 TO TREAT ACUTE MYOCARDIAL INFARCTION IN A PORCINE MODEL OF CORONARY ARTERY BANDING (LAP-BAND) AS TREATMENT FOR MORBID OBESITY IN ADOLESCENTS

Source: http://www.surgery.emory.edu/newsletter/2009_surgery_active_funding.pdf

Microsoft word - the people agenda.doc

DEKLARASYON DAGITI UMILI ITI ALDAW KORDILYERA 2010 PARA ITI PULITIKA TI Dakami nga umili ti Kordilyera, a nakipaset iti selebrasyon ti maikaduwapullo ket ennem nga Aldaw Kordilyera iti syudad ti Baguio ket nagkaykaysa iti daytoy a deklarasyon tapnu iyabante ti pulitika iti panagbalbaliw ken agenda dagiti umili kasilpu iti umasideg a May 10 elections. Kasta met a dakami a delegados a naga

Equistone launch 11 nov 11 french final 2

Communiqué de presse 11 Novembre 2011 Lancement d’Equistone Partners Europe Reprise de la société de gestion Barclays Private Equity (« BPE ») par ses équipes Equistone Partners Europe (« Equistone ») annonce la reprise de la société de gestion Barclays Private Equity, un des leaders européen du capital investissement sur le segment du mid-market. Equistone, sociétÃ

Copyright © 2010 Find Medical Article